Alaunos Therapeutics, Inc. Proceeds from Long-Term Debt Issued
Alaunos Therapeutics, Inc. (TCRT) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2023-03-07
- Alaunos Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2022-12-31 was $0.00.
- Alaunos Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2021-12-31 was $0.00.
- Alaunos Therapeutics, Inc. proceeds from issuance of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Alaunos Therapeutics, Inc. proceeds from issuance of long-term debt for fiscal 2021 was $25.00M.
- Alaunos Therapeutics, Inc. proceeds from issuance of long-term debt for fiscal 2020 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $0.00 10-K · filed 2023-03-07 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $25.00M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $25.00M 10-Q · filed 2022-11-14 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |